EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018-2021)

Antonia Da Fonseca Ioannou iD, Carolyn Tai, Mary Anna Labato iD, Emmanuelle M Butty iD

Journal of Veterinary Internal Medicine · 01.03.2024 · 38 (2) · 1051-1059

DOI: 10.1111/jvim.16998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 01.03.2024. Verfasst von Antonia Da Fonseca Ioannou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Tufts University, Cummings School of Veterinary Medicine, Foster Hospital for Small Animals, North Grafton, Massachu…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Dog Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Outcomes of dogs with acute kidney injury secondary to leptospirosis (AKI-L) treated using renal replacement therapies (RRT) are poorly characterized. Hypothesis/Objectives Describe survival to discharge, short (≤30 days) and long-term (≥6 months) outcomes of AKI-L dogs receiving RRT and determine if there is a significant difference in maximum blood urea nitrogen (maxBUN), maximum creatinine (maxCr), maximum bilirubin (maxBili) and the number of body systems affected between survivors and non-survivors. Animals Twenty-two client-owned dogs with AKI-L receiving RRT.

Methods

Retrospective medical record review of dogs with AKI-L that received RRT between 2018 and 2021.

Results

Sixteen of 22 (73%) dogs survived to discharge. Of the survivors, 13 (81%) were alive >30 days from discharge and 12 (75%) were alive at 6 months from discharge. Factors significantly higher in non-survivors included number of body systems affected (survivors: 1 (19%), 2 (50%), 3 (25%) and 4 (6%) vs non-survivors: 3 (33.3%), and 4 (66.7%); P = .01) and median maxBili (survivors: 1.9 mg/dL; range, 0.1-41.6 vs non-survivors: 21.0 mg/dL; range, 12.3-38.9; P = .02). There was no significant difference in median maxBUN (survivors: 153.0 mg/dL; range, 67-257 vs non-survivors: 185.5 mg/dL; range, 102-218; P = .44) and median maxCr (survivors: 9.8 mg/dL; range, 6.2-15.9 vs non-survivors: 9.8 mg/dL; range, 8.4-13.5; P = .69) between survivors and non-survivors. Conclusions and Clinical Importance Regardless of azotemia severity, dogs with AKI-L receiving RRT have a good survival rate to discharge. The number of body systems affected and hyperbilirubinemia might be associated with worse outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryDog DiseasesHumansDogsAnimalsRetrospective StudiesRenal Replacement TherapyBlood Urea Nitrogen

Stichwörter der Autor:innen

Leptospiraacute kidney injuryanuriaazotemiacaninecontinuous renal replacement therapyhemoperfusionintermittent hemodialysisoliguria

Autor:innen und Institutionen

  • Department of Clinical Sciences, Tufts University, Cummings School of Veterinary Medicine, Foster Hospital for Small Animals, North Grafton, Massachusetts, USA.

ORCID-Profile: Antonia Da Fonseca Ioannou, Mary Anna Labato, Emmanuelle M Butty

Zitieren

APA

Ioannou, A. D. F., Tai, C., Labato, M. A., & Butty, E. M. (2024). Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018-2021). Journal of Veterinary Internal Medicine, 38(2), 1051-1059. https://doi.org/10.1111/jvim.16998

Vancouver

Ioannou ADF, Tai C, Labato MA, Butty EM. Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018-2021). Journal of Veterinary Internal Medicine. 2024;38(2):1051-1059. doi:10.1111/jvim.16998

BibTeX
@article{Ioannou2024,
  author = {Ioannou, Antonia Da Fonseca and Tai, Carolyn and Labato, Mary Anna and Butty, Emmanuelle M},
  title = {Retrospective evaluation of 22 dogs with leptospirosis treated with extracorporeal renal replacement therapies (2018-2021)},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  volume = {38},
  number = {2},
  pages = {1051--1059},
  doi = {10.1111/jvim.16998}
}
Kostenlos starten →